ACCELERATED ENROLLMENT SOLUTIONS (AES) is a leading global provider of patient enrollment and retention services based in the United States. Established in 1999, AES has become a trusted partner for pharmaceutical, biotechnology, and medical device companies seeking to accelerate clinical trial enrollment and improve patient recruitment efforts. The company's headquarters is located in Phoenix, Arizona, where its dedicated team of enrollment experts work tirelessly to meet the needs of clients worldwide.

AES operates on a global scale, serving clients across North America, Europe, Asia-Pacific, and Latin America. The company has developed a strong network of clinical sites and partnerships with healthcare providers in these regions to identify and engage eligible patients. AES offers a range of products and services designed to enhance patient enrollment and retention rates.

Their comprehensive solutions include patient recruitment and screening, tele-recruitment, patient travel coordination, and retention programs. By leveraging advanced data analytics and targeted outreach strategies, AES helps its clients efficiently and effectively reach their enrollment goals. The company has several noteworthy partnerships and subsidiaries.

In 2015, AES became a subsidiary of Pharmaceutical Product Development, LLC (PPD), a global contract research organization. This collaboration has further strengthened AES's capabilities and global reach, allowing them to offer integrated solutions that address both enrollment and clinical trial management needs. In terms of market position, AES is recognized as a leading provider of patient enrollment and retention services globally.

With a proven track record of success, AES has established itself as the go-to solution for companies seeking to overcome recruitment challenges and expedite the clinical trial process. Their expertise and proven strategies give them a competitive edge in the industry. As of the latest updates, AES continues to expand its global footprint, collaborating with various pharmaceutical and biotech companies to drive patient enrollment in clinical trials.

The company remains committed to innovation and developing new strategies to optimize patient recruitment and retention efforts, ensuring the timely completion of clinical trials. In conclusion, ACCELERATED ENROLLMENT SOLUTIONS is a well-established player in the global patient enrollment and retention services market. With a strong market position, a comprehensive range of solutions, and a commitment to innovation, AES is poised for continued growth and success in the clinical trial industry